Keywords: idec, psoriasis, antibody, enters, phase, ii, pharmaceuticals

IDEC psoriasis antibody enters Phase II

Article | 01 February 2001

IDEC Pharmaceuticals has initiated a pilot Phase II trial of itsinvestigational drug IDEC-131, a humanized anti-CD154 (or anti-CD40L) monoclonal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Go to company listing